Jeff Schaffnit: The Power of Community in Rare Blood Disorders
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
”This week, I had the privilege of attending the National Bleeding Disorders Foundation (NBDF) Annual Meeting. As always, it’s incredibly inspiring to spend time with the bleeding disorders community and hear directly from the people at the heart of everything we do.
I’m grateful to the patients, caregivers, healthcare professionals, and advocates who shared their perspectives and reminded us why listening matters. Those insights help shape how we think about the future and strengthen our commitment to helping advance research and innovation for the rare blood disorders community.
Thank you to National Bleeding Disorders Foundation for bringing the community together and creating space for these important conversations. I look forward to continuing to work alongside our partners as Sanofi continues to chase the miracles of science for people living with rare blood disorders.”
Stay updated with Hemostasis Today.
-
Oct 2, 2026, 09:20Anticoagulants, Blood Thinners, or Antithrombotic Medications? – World Thrombosis Day
-
Oct 2, 2026, 06:00Susan Wickersham: Gradual Shift towards Autologous Blood Transfusion is a Current Trend
-
Oct 2, 2026, 05:54Shamee Shastry: When Every Cell Reacts – The Hunt for Rare Blood
-
Oct 2, 2026, 05:49David Mclntosh: Expanding Plasma Protein Therapies in Underserved Regions
-
Oct 2, 2026, 05:38Dianne E. van der Wal: C-Terminal Endings Impact PAR1/PAR4 Peptide Potency in In Vitro Platelet Assays
-
Oct 2, 2026, 05:29Mohammed Alo: Your LDL Isn’t a Snapshot – It’s a Smoking Habit Measured in Years
-
Oct 2, 2026, 00:33Marwa Mostafa: Hemoglobinopathies – When Globin Genes Go Wrong
-
Oct 1, 2026, 23:46Behnood Bikdeli: Global Burden of Venous Thromboembolism
-
Oct 1, 2026, 23:46Sthanu Subramanian: Clinical Presentation, Risk Factors, Diagnosis, and Neuroimaging Findings in CVT